Kasia Lipska MD, MHS, BSEndocrinologist, Yale School of Medicine; Clinical Investigator, Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut
Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). She completed her medical training at Harvard Medical School and her internal medicine training at the Brigham and Women’s Hospital. She spent a year taking care of patients with diabetes on the Navajo reservation and then went on to complete her endocrine training and the Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine. She spent a year in South India as part of a Fogarty sponsored fellowship pursuing research on cerebrovascular complications of diabetes. She is currently Instructor in the Department of Medicine and she conducts research to better understand the balance of harms and benefits of glucose-lowering therapy in older adults with type 2 diabetes. In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.
Dr. Lipska reports research funding from NIH and ADA/ASP. She also receives support from the Centers for Medicare & Medicaid Services (CMS) to develop publically reported quality measures.
Recent Contributions to PracticeUpdate:
- Effects of Glucose Control, Sulfonylurea, and Insulin in T2D
- Tread Softly: Glucose Lowering in Nursing Home Residents With Type 2 Diabetes
- Sulfonylureas and Risk of Falls and Fractures Among Nursing Home Residents With Type 2 Diabetes Mellitus
- Hypoglycemia Edges Out Hyperglycemia in Hospital Admissions for Diabetes